Cephalexin dosage in general practice assessed by double-blind trial.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D001991:Bronchitis / Q000188:drug therapy; D002506:Cephalexin / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004342:Drug Hypersensitivity / Q000209:etiology; D005194:Family Practice; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D007239:Infections / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009422:Nervous System Diseases / Q000139:chemically induced; D010032:Otitis Externa / Q000188:drug therapy; D010033:Otitis Media / Q000188:drug therapy; D012852:Sinusitis / Q000188:drug therapy; D013280:Stomatitis / Q000139:chemically induced; D014076:Tooth Diseases / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy; D014627:Vaginitis / Q000139:chemically induced
D002506:Cephalexin